Comprehensive meta-analysis of safety and efficacy of bivalirudin versus heparin with or without routine glycoprotein IIb/IIIa inhibitors in patients with acute coronary syndrome - Navarese, EP; Schulze, V; Andreotti, F (JACC Cardiovasc Interv, 2015)
et al.